Methods and compositions for treating melanoma
US-2024424002-A1 · Dec 26, 2024 · US
US2016136141A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016136141-A1 |
| Application number | US-201514937730-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 10, 2015 |
| Priority date | Mar 10, 2010 |
| Publication date | May 19, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A stable, taste-masked, ready-to-use suspension comprising rifaximin dispersed in a suspension base and one or more pharmaceutically acceptable additive(s). Also provided is a process for preparing a stable, taste-masked, ready-to-use suspension of rifaximin comprising the steps of mixing rifaximin with the suspension base and further sizing the particles of rifaximin by milling the suspension to obtain a homogenously dispersed rifaximin suspension.
Opening claim text (preview).
1 ) A stable, taste-masked, ready-to-use suspension comprising rifaximin dispersed in a suspension base and one or more pharmaceutically acceptable additive(s). 2 ) The stable, taste—masked, ready-to-use suspension as of claim 1 wherein one or more pharmaceutically acceptable additive(s) is selected from flavoring agent(s), sweetening agent(s), buffering agents(s), preservative(s), suspending agents(s), antioxidant(s), wetting agent(s), dispersing agent(s), pH stabilizing agent(s), taste enhancing agent(s), antifoaming agent(s) or mixtures thereof. 3 ) The stable, taste—masked, ready-to-use suspension as of claim 1 wherein the pH of the suspension is from about 2 to about 8. 4 ) The stable, taste—masked, ready-to-use suspension as of claim 1 wherein the viscosity of the suspension is from about 20 to about 200 Cps. 5 ) A stable taste—masked, ready-to-use suspension as of claim 1 wherein the d90 of rifaximin is less than about 40 μm. 6 ) A process for preparing stable, taste-masked, ready-to-use suspension of rifaximin wherein the said process comprises the steps of dispersing rifaximin in the suspension base comprising one or more pharmaceutically acceptable additive(s) and further milling the suspension to obtain a homogenously dispersed rifaximin suspension.
the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline · CPC title
Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof · CPC title
Dispersions; Emulsions · CPC title
Antibacterial agents · CPC title
condensed with carbocyclic rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.